WallStreetZenWallStreetZen

NASDAQ: OSUR
Orasure Technologies Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

OSUR past earnings growth

How has OSUR's earnings growth performed historically?
Company
N/A
Industry
27.17%
Market
61.16%
OSUR's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
OSUR's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance

OSUR past revenue growth

How has OSUR's revenue growth performed historically?
Company
4.64%
Industry
7.75%
Market
16.96%
OSUR's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
OSUR's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
OSUR's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

OSUR earnings and revenue history

Current Revenue
$405.5M
Current Earnings
$53.7M
Current Profit Margin
13.2%

OSUR Return on Equity

Current Company
13.2%
Current Industry
11.1%
Current Market
188%
OSUR's Return on Equity (13.2%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when OSUR announces earnings.

OSUR Return on Assets

Current Company
11.6%
Current Industry
7.2%
OSUR is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

OSUR Return on Capital Employed

Current Company
12.69%
Current Industry
9.7%
OSUR has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

OSUR vs Medical Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
OSUR$405.47M$77.19M$53.66M+17.41%+17.21%
PLSE$0.00-$42.37M-$42.21M-100.00%N/A
NYXH$4.73M-$41.92M-$46.97M+383.53%N/A
SMTI$64.99M$190.58k-$4.30M+61.93%N/A
ZJYLN/AN/AN/AN/AN/A
View Top Medical Stocks

OSUR earnings dates

Next earnings date
May 8, 2024

Orasure Technologies Earnings & Revenue FAQ

What were OSUR's earnings last quarter?

On Invalid Date, Orasure Technologies (NASDAQ: OSUR) reported Q4 2023 earnings per share (EPS) of $0.27, up 28.57% year over year. Total Orasure Technologies earnings for the quarter were $20.07 million. In the same quarter last year, Orasure Technologies's earnings per share (EPS) was $0.21.

If you're new to stock investing, here's how to buy Orasure Technologies stock.

What was OSUR's earnings growth in the past year?

As of Q2 2024, Orasure Technologies's earnings has grown year over year. Orasure Technologies's earnings in the past year totalled $53.66 million.

What is OSUR's earnings date?

Orasure Technologies's earnings date is Invalid Date. Add OSUR to your watchlist to be reminded of OSUR's next earnings announcement.

What was OSUR's revenue last quarter?

On Invalid Date, Orasure Technologies (NASDAQ: OSUR) reported Q4 2023 revenue of $75.88 million up 38.35% year over year. In the same quarter last year, Orasure Technologies's revenue was $123.08 million.

What was OSUR's revenue growth in the past year?

As of Q2 2024, Orasure Technologies's revenue has grown 4.64% year over year. This is 3.11 percentage points lower than the US Medical Instruments & Supplies industry revenue growth rate of 7.75%. Orasure Technologies's revenue in the past year totalled $405.47 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.